Jeroen de Ridder

Full Professor

Strategic program(s):

Contact

jridder4@umcutrecht.nl

Pure profile

Research groups

Bioinformatics in molecular medicine

Research aim

We are a bioinformatics lab that creates and applies innovative data science methods to advance our understanding of disease biology and molecular medicine with a focus on cancer research.

Go to group

Recent publications

All publications

Glioblastoma, IDH-wildtype with primarily leptomeningeal localization diagnosed by nanopore sequencing of cell-free DNA from cerebrospinal fluid Nik Sol, Evert Jan Kooi, Marc Pagès-Gallego, Dieta Brandsma, Marianna Bugiani, Jeroen de Ridder, Pieter Wesseling, Carlo Vermeulen
Acta Neuropathologica, 2024, vol. 148, p.1-4

Co-expression in tissue-specific gene networks links genes in cancer-susceptibility loci to known somatic driver genes Carlos G. Urzúa-Traslaviña, Tijs van Lieshout, Floranne Boulogne, Kevin Domanegg, Mahmoud Zidan, Olivier B. Bakker, Annique Claringbould, Jeroen de Ridder, Wilbert Zwart, Harm Jan Westra, Patrick Deelen, Lude Franke
BMC Medical Genomics, 2024, vol. 17

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer Alaa Embaby, Joachim Kutzera, Jill J Geenen, Dick Pluim, Ingrid Hofland, Joyce Sanders, Marta Lopez-Yurda, Jos H Beijnen, Alwin D R Huitema, Petronella O Witteveen, Neeltje Steeghs, Gijs van Haaften, Marcel A T M van Vugt, Jeroen de Ridder, Frans L Opdam
Gynecologic Oncology, 2023, vol. 174, p.239-246

Author Correction Alessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H van Ginkel, Boris Peltenburg, Li-Ting Chen, Ivo Renkens, Joyce van Kuik, Chris Terhaard, Remco de Bree, Lot A Devriese, Stefan M Willems, Wigard P Kloosterman, Jeroen de Ridder
npj Genomic Medicine, 2023, vol. 8

Echtvar Brent S. Pedersen, Jeroen de Ridder
Nucleic acids research, 2023, vol. 51, p.1-8

Comprehensive benchmark and architectural analysis of deep learning models for nanopore sequencing basecalling Marc Pagès-Gallego, Jeroen de Ridder
Genome Biology, 2023, vol. 24, p.1-18

External positions

Chief Science Officer - Management of R&D and science activities - Cyclomics BV